Company: RNAC
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001453687-25-000140
Chunk: 3

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Exhibit Description                                                          
 ────────────────────────────────────────────────────────────────────────────────────────────────
         14.1      Cartesian Therapeutics, Inc. Code of Business Conduct and Ethics             
         99.1      Press Release of Cartesian Therapeutics, Inc., dated December 18, 2025       
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CARTESIAN THERAPEUTICS, INC.                                             
  By:                               /s/ Carsten Brunn, Ph. D.              
                                    Carsten Brunn, Ph. D.                  
                                    President and Chief Executive Officer